The Moderna News That Has MRNA Stock Price Surging: 3 Key Catalysts

Moderna (NASDAQ:MRNA) stock is up more than 20% in just the past five trading sessions as investors foresee strong growth opportunities for the biotechnology firm. Indeed, the company has climbed 44% so far this year as one of the big winners of 2024's bull market. What's pushing MRNA stock up lately? Well, it appears the company is benefitting primarily from three main drivers: MRNA Stock Climbs Despite Mixed Analyst Ratings While Moderna has plenty of potential growth avenues, some believe MRNA stock may ...